- Co. listed estimated assets and liabilities each in the $1 million to $10 million range
- It said in a November
filing that stockholders didn’t approve a plan to liquidate and dissolve the company upon completion of an asset sale
- It said in a November
- Co. develops Camelina varieties for seed products, including feedstock oils, nutritional oils, and PHA bioplastics, according to its website
- The case is Yield10 Bioscience, Inc.,
24-12752 , in U.S. Bankruptcy Court District of Delaware
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.